These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1735699

  • 1. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
    Kagiya VT, Nishimoto S, Ito T, Wang J, Abe M, Sasai K.
    Int J Radiat Oncol Biol Phys; 1992; 22(3):601-5. PubMed ID: 1735699
    [Abstract] [Full Text] [Related]

  • 2. Importance of tumor affinity of nitroazoles in hypoxic radiosensitization.
    Kagiya T, Nishimoto S, Shibamoto Y, Wang J, Zhou L, He YL, Sasai K, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1033-7. PubMed ID: 2703382
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
    Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T.
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H, Bando M, Hori H, Satoh T, Tada T, Onoyama Y, Inayama S.
    Int J Radiat Oncol Biol Phys; 1992 Jun; 22(3):561-4. PubMed ID: 1735696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sensitization by SR-2508 plus Ro 03-8799.
    Stone HB, Luu YH, Lam KN.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1097-100. PubMed ID: 2943707
    [Abstract] [Full Text] [Related]

  • 14. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
    Zhou L, Nishimoto S.
    Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
    [Abstract] [Full Text] [Related]

  • 15. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]

  • 16. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW, Morrissey S, Wolf K.
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [Abstract] [Full Text] [Related]

  • 17. Metabolic studies and neurotoxicity in tumors and brain of mice after hypoxic cell sensitizers.
    Streffer C, Tamulevicius P.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):571-5. PubMed ID: 8005816
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 20. Hypoxic cell radiosensitizers: expectations and progress in drug development.
    Coleman CN.
    Int J Radiat Oncol Biol Phys; 1985 Feb 15; 11(2):323-9. PubMed ID: 3156109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.